Allergy to cats and dogs is extremely common and occurs in up to 25% of people with allergies. Cat allergies are twice as common as dog allergies. Cat allergens are produced in large amounts, particularly by male non-neutered cats. The allergens are partially under hormonal control. Cats produce a protein known as Fel d 1, which is allergenic to human beings when it is infected with bacteria or viruses. The infected protein is contained in a pet’s urine, saliva, and skin. The dead skin of pets known as dander is regularly sloughed off and replaced by new skin cells. The dander can flake off from a pet’s fur and become airborne. It can be carried on the clothing of people who have pets such as cats and dogs and then shed in public places. Therefore, pet allergens especially that of cats and dogs, are a component of house dust even in homes where cats and dogs have never lived.

Market Analysis and Insights: Global Pet Allergy Treatment Drugs Market
The global Pet Allergy Treatment Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Pet Allergy Treatment Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Pet Allergy Treatment Drugs market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Pet Allergy Treatment Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Pet Allergy Treatment Drugs market.

Global Pet Allergy Treatment Drugs Scope and Market Size
Pet Allergy Treatment Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Pet Allergy Treatment Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Antihistamines
Decongestants
Corticosteroid
Others

Segment by Application
Dog
Cat
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Sunovion Pharmaceuticals Inc
Allergon AB
AbbVie(Allergan)
HAL Allergy Group
Allergy Therapeutics
Teva Pharmaceutical
Viatris
GlaxoSmithKline
Stallergenes Greer